创新药再度走强能否成为市场阶段主线?中国银河证券财富星首席投资顾问高乐认为政策持续加码创新药商务拓展预期多增;五矿证券投

智通财经
Yesterday
创新药再度走强能否成为市场阶段主线?中国银河证券财富星首席投资顾问高乐认为政策持续加码创新药商务拓展预期多增;五矿证券投资顾问梁承伟认为政策助力创新药大发展;华福证券许鸣鸣认为创新药基本面持续改善有利于股价修复但高位博弈波动会加大。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10